TCI Healthcare Software

South East, USA

Short Summary

Last year, 50% of all hospitals in the U.S. were penalized an average of $1.2 million each for failing to report patient satisfaction & quality of care data on time. TCI software products mitigate this exposure for as little as $395 p/mo.

Highlights

  • Invoiced more in 1Q 2018 than in all of 2017
  • Went to cash flow positive status in 2Q 2018.
  • Should have a $100 million market value in 36 months
  • Plan to give investors a 10X return
  • Software deployed in 80 locations in 12 states in first 12 months
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
US$500,000
Minimum
US$50,000
Investment Raised
N/A
Previous Rounds US$600,000
Stage Breaking Even
Investor Role

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 195,403 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Featured
6% raised

Trillum Eye Care Pre-IPO

South East, USA

Join this international health care group expand clinics in North America. Convertible Note pays 10% interest which converts into Stock pre-IPO. Company is targeting an IPO in the US.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

Global Pro
0% raised

Hemp with a Heart

West, USA

Our organic cannabinoid extracts have been chosen by Kevin Harrington to produce our very own DRTV commercial featuring our unique difference in the marketplace. At NOHI, we support complete healing through education, co-creation, and empowerment.

US$ 125,000

Target

US$ 500

Min per Investor

Global Pro
0% raised

New Rotator Cuff Product

North East, USA

We have issued patents for a new breakthrough technology that will greatly improve the standard of care for rotator cuff tears and at the same time reduce medical spending. This investment will bring this new product to the FDA for approval.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

load one similar proposal